Skip to main content
. 2018 May 9;2018(5):CD009069. doi: 10.1002/14651858.CD009069.pub3

2.9. Analysis.

Comparison 2 High‐grade cervical lesions in HPV16/18 DNA negative women at baseline, Outcome 9 CIN3+ associated with HPV16/18 or HPV6/11/16/18, 1 or 2 doses (post hoc analysis).